Patents by Inventor Peter Söhlemann

Peter Söhlemann has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Processing of recombinant human G-CSF precursor
    Patent number: 8436142
    Abstract: A G-CSF precursor comprising a signal peptide and a G-CSF peptide, wherein the signal peptide has the sequence of the human wild-type signal peptide of the human G-CSF/b molecule with at least one of the following mutations: deletion of Glu29, insertion of Glu26, substitution Lys11Leu, substitution His21Phe, and substitution Gln28Leu.
    Type: Grant
    Filed: October 2, 2009
    Date of Patent: May 7, 2013
    Assignee: Octapharma AG
    Inventors: Carola Schröder, Elisabeth Casademunt, Peter Söhlemann, Michael Lehnerer
  • PROCESSING OF RECOMBINANT HUMAN G-CSF
    Publication number: 20110294989
    Abstract: A G-CSF precursor comprising a signal peptide and a G-CSF peptide, wherein the signal peptide has the sequence of the human wild-type signal peptide of the human G-CSF/b molecule with at least one of the following mutations: deletion of Glu29, insertion of Glu26, substitution Lys11Leu, substitution His21Phe, and substitution Glu28Leu.
    Type: Application
    Filed: October 2, 2009
    Publication date: December 1, 2011
    Applicant: OCTOPHARMA BIOPHARMACEUTICALS GMBH
    Inventors: Carola Schröder, Elisabeth Casademunt, Peter Söhlemann, Michael Lehnerer